Your email has been successfully added to our mailing list.

×
-0.00767148014440425 -0.00767148014440425 -0.00767148014440425 -0.00767148014440425 -0.000902527075812255 -0.0143682310469314 -0.0143682310469314 -0.0143682310469314
Stock impact report

VanEck Vectors Morningstar Wide Moat ETF (MOAT) August Summary [Seeking Alpha]

VAN ECK VECTORS GENERIC DRUGS ETF (GNRX) 
US:NASDAQ Investor Relations: vaneck.com/etf/equity/gnrx/overview
Company Research Source: Seeking Alpha
August monthly performance was: AUM of $1.28B 52-week performance vs. the S&P 500 is: No dividends were paid in August Top 10 Holdings as of 8/31/2017: Gilead Sciences Inc ( GILD ): 3.10975%, Guidewire Software Inc ( GWRE ): 2.97895%, Biogen Inc ( BIIB ): 2.9496%, VF Corp ( VFC ): 2.88204%, Visa Inc Class A ( V ): 2.73694%, Bristol-Myers Squibb Company ( BMY ): 2.71876%, Salesforce.com Inc ( CRM ): 2.7005%, Polaris Industries Inc ( PII ): 2.69259%, Amgen Inc ( AMGN ): 2.6372%, Amazon.com Inc ( AMZN ): 2.60426% Show less Read more
Impact Snapshot
Event Time:
GNRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for GNRX alerts
Opt-in for
GNRX alerts

from News Quantified
Opt-in for
GNRX alerts

from News Quantified